Income statement
CAD
Annual
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 10K | 42K | 88K | 201K |
| Gross Profit | 0 | 6K | 30K | 22K | 108K |
| Operating Income | -1M | -333K | -502K | -1M | -5M |
| EBITDA | -780K | 190K | 44K | -3M | -5M |
| Net Income | -1M | 183K | -118K | -3M | -5M |
| EPS (Diluted) | — | — | — | — | — |
Healthcare
Live Price
Offline$0.4989
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 9, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 9, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Sweet Earth Holdings Corporation (SEHCF) is a Healthcare stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.50 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 9, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of -185.7%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS -185.7%, free cash flow -1452.0% with operating margin 0.0% and ROIC -38.0%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SEHCF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
SEHCF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
SEHCF Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for SEHCF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$200.7K
+127.8% YoY
FY Net Income
-$4.9M
-56.3% YoY
Free Cash Flow
-$3.6M
-294.3% YoY
Revenue Growth
-100.0%
EPS Growth
-185.7%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 10K | 42K | 88K | 201K |
| Gross Profit | 0 | 6K | 30K | 22K | 108K |
| Operating Income | -1M | -333K | -502K | -1M | -5M |
| EBITDA | -780K | 190K | 44K | -3M | -5M |
| Net Income | -1M | 183K | -118K | -3M | -5M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3M | 18K | 155K | 135K | 85K |
| Total Assets | 2M | 18K | 168K | 1M | 3M |
| Total Liabilities | 3M | 305K | 641K | 2M | 2M |
| Shareholder Equity | -6K | -287K | -473K | -840K | 881K |
| Total Debt | 2M | 50K | 30K | 1M | 1M |
| Net Debt | -117K | 33K | -125K | 978K | 1M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
4M
-302.8% YoY
Capital Expenditures
0
+100.0% YoY
Free Cash Flow
4M
-294.3% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-830.4%
Debt / Equity
-327.42x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.